These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2014045)

  • 1. Experimental therapy--who shall pay?
    N Engl J Med; 1991 May; 324(18):1291-2. PubMed ID: 2014045
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining experimental therapy--a third-party payer's dilemma.
    Newcomer LN
    N Engl J Med; 1990 Dec; 323(24):1702-4. PubMed ID: 2233969
    [No Abstract]   [Full Text] [Related]  

  • 3. Who should be responsible?
    Brown E
    Physician Exec; 1996 Jun; 22(6):38-9. PubMed ID: 10158532
    [No Abstract]   [Full Text] [Related]  

  • 4. Will insurers pay for high-tech care?
    Crane M
    Med Econ; 1991 Apr; 68(8):82-6. PubMed ID: 10110091
    [No Abstract]   [Full Text] [Related]  

  • 5. Reimbursing new technologies: why are the courts judging experimental medicine?
    Saver RS
    Stanford Law Rev; 1992 May; 44(5):1095-131. PubMed ID: 10119850
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparing for the introduction of new technologies: who is going to pay for them?
    Marshall PR
    J Cardiovasc Manag; 2002; 13(1):14-20. PubMed ID: 11828780
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of medical-technology strategies: proposal for an institute for health-care evaluation (second of two parts).
    Bunker JP; Fowles J; Schaffarzick R
    N Engl J Med; 1982 Mar; 306(11):687-92. PubMed ID: 7035949
    [No Abstract]   [Full Text] [Related]  

  • 8. Popping the cost balloon. Angioplasty study should be a harbinger, but budgets, entropy stall reform.
    Sloane T
    Mod Healthc; 2007 Apr; 37(15):21. PubMed ID: 17494354
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of medical-technology strategies: effects of coverage and reimbursement (first of two parts).
    Bunker JP; Fowles J; Schaffarzick R
    N Engl J Med; 1982 Mar; 306(10):620-4. PubMed ID: 7035944
    [No Abstract]   [Full Text] [Related]  

  • 10. How can Medicare keep pace with cutting-edge technology?
    Buto KA
    Health Aff (Millwood); 1994; 13(3):137-40. PubMed ID: 7927144
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to investigational treatments.
    Ader M
    Health Matrix Clevel; 1996; 6(1):187-99. PubMed ID: 10167167
    [No Abstract]   [Full Text] [Related]  

  • 12. Who pays for clinical research?
    Weiss GB
    Clin Res; 1979 Oct; 27(4):297-9. PubMed ID: 10309043
    [No Abstract]   [Full Text] [Related]  

  • 13. Reimbursement for clinical investigation.
    Oldham RK
    Pharos Alpha Omega Alpha Honor Med Soc; 1991; 54(2):33. PubMed ID: 2068219
    [No Abstract]   [Full Text] [Related]  

  • 14. Third-party payers and investigational therapy.
    N Engl J Med; 1988 Nov; 319(18):1228. PubMed ID: 3173464
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental treatment: who pays?
    Lenow JL; Quentzel S
    Bus Health; 1991 Oct; 9(11):104-5. PubMed ID: 10115050
    [No Abstract]   [Full Text] [Related]  

  • 16. Who should rightfully decide whether a medical treatment necessarily incurred should be excluded from coverage under a health insurance policy provision which excludes from coverage "experimental" medical treatments?
    Fisfis BA
    Spec Law Dig Health Care Law; 1994 Mar; (181):9-32. PubMed ID: 10133063
    [No Abstract]   [Full Text] [Related]  

  • 17. Reimbursement disputes involving experimental medical treatment.
    Molino PJ
    J Health Hosp Law; 1991 Nov; 24(11):329-36, 343, 359. PubMed ID: 10114834
    [No Abstract]   [Full Text] [Related]  

  • 18. The crisis in clinical cancer research. Third-party insurance and investigational therapy.
    Antman K; Schnipper LE; Frei E
    N Engl J Med; 1988 Jul; 319(1):46-8. PubMed ID: 3288868
    [No Abstract]   [Full Text] [Related]  

  • 19. A swift response to a "modest" proposal.
    Cova JL
    J Natl Cancer Inst; 1992 May; 84(10):744-5. PubMed ID: 1573657
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical technology and the reimbursement dilemma.
    Dragalin D
    Internist; 1992 Oct; 33(9):12-4. PubMed ID: 10121371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.